Healthcare Company Pops On Oversubscribed Private Placement

Healthcare Company Pops On Oversubscribed Private Placement

By: Dylan Sikes – News

Thursday, January 21, 2021

A small Calgary-based healthcare company announced today the closing of an oversubscribed $2.5 Million private placement financing as well as communications engagement for investor relations services. FluroTech Ltd. (TSX-Venture:TEST) said that in the second and final tranche of its non-brokered private placement, 15,644,844 units were sold at a price of $0.135 per unit. 

FluroTech Ltd. is a technology and marketing company. Its core business is focused on the commercialization of new technologies in the cannabis hemp industries. Its product includes CompleTest.

Traders seemed to be optimistic on the news as shares rose to a session high of $.47/share (+30.5%). This move is a continuation of the success the stock has had over the last month as well as a bullish breakout above a prior resistance level set back in September 2020.

Copyright © 2021 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

With Inflation Expectations Rising, Junior Miners Could Be Setting Up For A Major Bullish Rally
California Company Expecting Expansion
Micro Cap Tech Firm Announces New Global Customers
Most Popular
FREE Newsletter

Back to Top